14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.24 $2.30 Friday, 3rd May 2024 ATOS stock ended at $1.66. This is 9.21% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 11.11% from a day low at $1.53 to a day high of $1.70.
90 days $0.83 $2.30
52 weeks $0.622 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
May 05, 2023 $0.690 $0.699 $0.659 $0.686 286 771
May 04, 2023 $0.650 $0.680 $0.625 $0.677 339 550
May 03, 2023 $0.650 $0.699 $0.625 $0.662 483 150
May 02, 2023 $0.640 $0.640 $0.600 $0.640 310 101
May 01, 2023 $0.649 $0.650 $0.600 $0.600 219 326
Apr 28, 2023 $0.634 $0.649 $0.630 $0.639 185 307
Apr 27, 2023 $0.610 $0.650 $0.590 $0.634 404 475
Apr 26, 2023 $0.620 $0.647 $0.600 $0.605 269 294
Apr 25, 2023 $0.670 $0.672 $0.623 $0.635 582 884
Apr 24, 2023 $0.694 $0.720 $0.663 $0.672 488 129
Apr 21, 2023 $0.720 $0.720 $0.690 $0.700 218 168
Apr 20, 2023 $0.730 $0.750 $0.715 $0.716 195 380
Apr 19, 2023 $0.760 $0.760 $0.730 $0.745 175 440
Apr 18, 2023 $0.740 $0.758 $0.730 $0.750 136 781
Apr 17, 2023 $0.745 $0.760 $0.715 $0.740 239 039
Apr 14, 2023 $0.737 $0.766 $0.725 $0.735 260 424
Apr 13, 2023 $0.720 $0.745 $0.710 $0.740 164 874
Apr 12, 2023 $0.745 $0.745 $0.715 $0.721 190 696
Apr 11, 2023 $0.690 $0.740 $0.690 $0.740 254 357
Apr 10, 2023 $0.710 $0.730 $0.690 $0.706 210 481
Apr 06, 2023 $0.710 $0.729 $0.700 $0.724 130 387
Apr 05, 2023 $0.750 $0.750 $0.693 $0.714 337 227
Apr 04, 2023 $0.730 $0.750 $0.712 $0.716 160 480
Apr 03, 2023 $0.710 $0.750 $0.710 $0.750 405 711
Mar 31, 2023 $0.700 $0.730 $0.691 $0.725 337 467
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT